These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 30528891)

  • 1. Response assessment after (chemo)radiotherapy for rectal cancer: Why are we missing complete responses with MRI and endoscopy?
    van der Sande ME; Beets GL; Hupkens BJ; Breukink SO; Melenhorst J; Bakers FC; Lambregts DM; Grabsch HI; Beets-Tan RG; Maas M
    Eur J Surg Oncol; 2019 Jun; 45(6):1011-1017. PubMed ID: 30528891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy.
    Napoletano M; Mazzucca D; Prosperi E; Aisa MC; Lupattelli M; Aristei C; Scialpi M
    Abdom Radiol (NY); 2019 Nov; 44(11):3664-3673. PubMed ID: 31004202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted MRI to assess response to chemoradiotherapy in rectal cancer: main interpretation pitfalls and their use for teaching.
    Lambregts DMJ; van Heeswijk MM; Delli Pizzi A; van Elderen SGC; Andrade L; Peters NHGM; Kint PAM; Osinga-de Jong M; Bipat S; Ooms R; Lahaye MJ; Maas M; Beets GL; Bakers FCH; Beets-Tan RGH
    Eur Radiol; 2017 Oct; 27(10):4445-4454. PubMed ID: 28409357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study.
    Lambregts DM; Rao SX; Sassen S; Martens MH; Heijnen LA; Buijsen J; Sosef M; Beets GL; Vliegen RA; Beets-Tan RG
    Ann Surg; 2015 Dec; 262(6):1034-9. PubMed ID: 25211270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is it time to rethink the rule of total mesorectal excision? A prospective radiological and pathological study in 49 consecutive patients with mid-rectal cancer.
    Guedj N; Zappa M; Maggiori L; Bertin C; Hennequin C; Panis Y
    Colorectal Dis; 2016 Sep; 18(9):O314-21. PubMed ID: 27381492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment.
    Maas M; Lambregts DM; Nelemans PJ; Heijnen LA; Martens MH; Leijtens JW; Sosef M; Hulsewé KW; Hoff C; Breukink SO; Stassen L; Beets-Tan RG; Beets GL
    Ann Surg Oncol; 2015 Nov; 22(12):3873-80. PubMed ID: 26198074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study.
    Gérard JP; Barbet N; Gal J; Dejean C; Evesque L; Doyen J; Coquard R; Gugenheim J; Benizri E; Schiappa R; Baudin G; Benezery K; François E
    Eur J Cancer; 2019 Feb; 108():1-16. PubMed ID: 30580125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer.
    Ippolito D; Drago SG; Pecorelli A; Maino C; Querques G; Mariani I; Franzesi CT; Sironi S
    World J Gastroenterol; 2020 May; 26(20):2657-2668. PubMed ID: 32523318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pattern-Based Approach Combining Tumor Morphology on MRI With Distinct Signal Patterns on Diffusion-Weighted Imaging to Assess Response of Rectal Tumors After Chemoradiotherapy.
    Lambregts DMJ; Delli Pizzi A; Lahaye MJ; van Griethuysen JJM; Maas M; Beets GL; Bakers FCH; Beets-Tan RGH
    Dis Colon Rectum; 2018 Mar; 61(3):328-337. PubMed ID: 29369900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic MRI after induction chemotherapy and before long-course chemoradiation therapy for rectal cancer: What are the imaging findings?
    Gollub MJ; Blazic I; Bates DDB; Campbell N; Knezevic A; Gonen M; Lynn P; Weiser MR; Garcia-Aguilar J; Hötker AM; Cercek A; Saltz L
    Eur Radiol; 2019 Apr; 29(4):1733-1742. PubMed ID: 30280248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer.
    Kim S; Han K; Seo N; Kim HJ; Kim MJ; Koom WS; Ahn JB; Lim JS
    Eur Radiol; 2018 Dec; 28(12):5231-5240. PubMed ID: 29858637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The surgical significance of residual mucosal abnormalities in rectal cancer following neoadjuvant chemoradiotherapy.
    Smith FM; Chang KH; Sheahan K; Hyland J; O'Connell PR; Winter DC
    Br J Surg; 2012 Jul; 99(7):993-1001. PubMed ID: 22351592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI-based guidelines for selective neoadjuvant treatment in rectal cancer: Does MRI adequately predict the indication for radiotherapy in daily practice in a large teaching hospital.
    Tersteeg JJC; Crolla RMPH; Gobardhan PD; Kint PAM; Niers-Stobbe I; Boonman-de Winter L; Arnold DE; Rozema T; Schreinemakers JMJ
    Eur J Cancer Care (Engl); 2020 Mar; 29(2):e13190. PubMed ID: 31863608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DWI for Assessment of Rectal Cancer Nodes After Chemoradiotherapy: Is the Absence of Nodes at DWI Proof of a Negative Nodal Status?
    van Heeswijk MM; Lambregts DM; Palm WM; Hendriks BM; Maas M; Beets GL; Beets-Tan RG
    AJR Am J Roentgenol; 2017 Mar; 208(3):W79-W84. PubMed ID: 27959622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters.
    Hötker AM; Tarlinton L; Mazaheri Y; Woo KM; Gönen M; Saltz LB; Goodman KA; Garcia-Aguilar J; Gollub MJ
    Eur Radiol; 2016 Dec; 26(12):4303-4312. PubMed ID: 26945761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ Preservation in the Treatment of Stage II and III Rectal Cancer.
    Hagen ER; Cleary RK
    Dis Colon Rectum; 2020 Sep; 63(9):1185-1189. PubMed ID: 33216489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term imaging characteristics of clinical complete responders during watch-and-wait for rectal cancer-an evaluation of over 1500 MRIs.
    Lambregts DMJ; Maas M; Boellaard TN; Delli Pizzi A; van der Sande ME; Hupkens BJP; Lahaye MJ; Bakers FCH; Beets GL; Beets-Tan RGH
    Eur Radiol; 2020 Jan; 30(1):272-280. PubMed ID: 31428827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI Assessment of Complete Response to Preoperative Chemoradiation Therapy for Rectal Cancer: 2020 Guide for Practice from the Korean Society of Abdominal Radiology.
    Park SH; Cho SH; Choi SH; Jang JK; Kim MJ; Kim SH; Lim JS; Moon SK; Park JH; Seo N;
    Korean J Radiol; 2020 Jul; 21(7):812-828. PubMed ID: 32524782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI and diffusion-weighted MRI to diagnose a local tumour regrowth during long-term follow-up of rectal cancer patients treated with organ preservation after chemoradiotherapy.
    Lambregts DM; Lahaye MJ; Heijnen LA; Martens MH; Maas M; Beets GL; Beets-Tan RG
    Eur Radiol; 2016 Jul; 26(7):2118-25. PubMed ID: 26518582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer.
    Li Y; Liu W; Pei Q; Zhao L; Güngör C; Zhu H; Song X; Li C; Zhou Z; Xu Y; Wang D; Tan F; Yang P; Pei H
    Cancer Med; 2019 Dec; 8(17):7244-7252. PubMed ID: 31642204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.